Table 3.
Comparison of CGM data between the two groups of patients after the intervention
| Parameters | App group (n = 43) | Control group (n = 43) | P |
|---|---|---|---|
| MG (mmol/L) | 9.01 (8.04, 9.70) | 10.45 (8.78, 12.27) | 0.003 |
| SD (mmol/L) | 3.00 (2.29, 3.46) | 3.48 (2.84, 4.04) | 0.011 |
| CV (%) | 0.34 (0.28, 0.37) | 0.33 (0.27, 0.38) | 0.757 |
| MAGE (mmol/L) | 7.28 (5.80, 8.39) | 7.98 (6.82, 9.44) | 0.018 |
| MODD (mmol/L) | 2.42 (1.91, 2.76) | 2.85 (2.13, 3.47) | 0.018 |
| LAGE (mmol/L) | 14.20 (12.10, 17.80) | 16.10 (13.15, 18.85) | 0.029 |
| TIR (%) | 64.0 (51.0, 73.0) | 47.0 (29.5, 67.0) | 0.001 |
| TAR (%) | 35.0 (23.0, 47.0) | 52.0 (29.5, 70.0) | 0.003 |
| TBR (%) | 1.0 (0, 2.0) | 0 (0, 2.5) | 0.469 |
| GMI (%) | 7.81 (7.09, 8.59) | 7.19 (6.77, 7.49) | 0.003 |
| GRI | 35.84 (28.44, 52.60) | 62.98 (39.50, 83.07) | 0.000 |
MG Mean glucose, CV coefficient of variation, SD standard deviation, MAGE mean amplitude of glucose excursions, MODD mean of daily difference, LAGE largest amplitude of glycemic excursion, Min-GM minimum glucose, Max-G maximum glucose, TIR time in range, TAR time above range, TBR time below range, GMI glucose management index, GRI glycemic risk index